Best Life Sciences Tech Companies in Delaware, United States
The 36 best Life Sciences Tech companies in Delaware, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Earendil.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Delaware
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Earendil Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics 45Funding top 12%AI top 35%Talent top 38%Patents top 46% All 8 signals ▾Fundingtop 12% AItop 35% Talenttop 38% Patentstop 46% Innovationtop 50% Globaltop 50% Techbottom 36% Marketbottom 25% Funding: Raised $787M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) AI: Product described with: ai-driven, deep learning rank vs industry peers · Fliar Intelligence Index 45/100 | $787M | 6 mo ago | Series D | Zhenping Zhu Co-Founder & Co-CEO | 2021 | GoDaddy Website BuilderReactRequireJS+8 | 6 patents Therapeutic and bispecific antibodies targeting TL1A for immune modulation | — |
| 2 | 4G Clinical Randomization and Trial Supply Management (RTSM) solutions for clinical trials | $259M | 62 mo ago | Series C | — | 2015 | HubSpot CMS HubBootstrapAmazon Web Services+21 | 23 patents Clinical trial supply forecasting and randomization validation software platforms | 1 job opening |
| 3 | Converge Developer of GenAI computational tools for drug discovery and manufacturing | $30M | 11 mo ago | Series A | Dov Gertz Co-Founder & CEO | 2024 | Framer SitesApple iCloud MailGoogle Workspace+21 | — | — |
| 4 | Leucine Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory | $8M | 35 mo ago | Series A | Vivek Gera Co-Founder & CEO | 2015 | WebflowGSAPStripe+21 | — | — |
| 5 | Inteliquet Provider of market research and consulting services for pharmaceutical companies | $7M | 144 mo ago | Series A | Jean Roberson CFO | 2010 | — | 6 patents Automated metadata extraction and classification-code parsing for software development tools. | — |
| 6 | RxWare Provider of solutions for managing manufacturing operations in manufacturing industries | $7M | 13 mo ago | Series A | — | 2013 | — | — | — |
| 7 | Electronic Lab Logs Provider of cloud-based electronic laboratory log management platform | $4M | 26 mo ago | Seed | Daniel Summers Founder & CEO | 2013 | TypeScriptChart.jsBootstrap+19 | — | — |
| 8 | NucsAI AI-powered healthcare platform for advanced analysis of tumor lesions | $4M | 24 mo ago | Seed | Nijat Ahmadov Co-Founder & CEO | 2024 | WebflowRecruiteejsDelivr+9 | — | — |
| 9 | logicflo.ai Provider of an AI agent workforce tailored for life sciences companies | $3M | 14 mo ago | Seed | Arun Ramakrishnan Co-Founder | 2024 | — | — | — |
| 10 | Halo Columns Developer of high-performance liquid chromatography columns for researchers | $873K | 38 mo ago | Funding Raised | — | 2005 | Cart FunctionalityWooCommerceWordPress+32 | — | — |
| 11 | BioCurie AI-based software for cell and gene therapy | $500K | 15 mo ago | Seed | Irene Rombel Co-Founder & CEO | 2021 | — | 7 patents AI-driven biopharmaceutical process development and manufacturing | — |
| 12 | Microbial Identification Chromatography solutions for microbiology and forensics, including software and testing services | $347K | 96 mo ago | Acquired | — | 1991 | — | — | — |
| 13 | Toolchest Provider of an API for data analytics | $125K | 49 mo ago | Deadpooled | Bryce Cai Co-Founder & CTO | 2021 | — | — | — |
Top 12 Life Sciences Tech companies in Delaware
#1
Series D · Middletown, Delaware · founded 2021$787Mraised▾
Provider of AI-driven technology platforms that enable the discovery and development of protein therapeutics. It transform the discovery of protein therapeutics using deep learning and high-throughput biology. The company aims to deliver transformative medicines to patients worldwide through its innovative approaches.
- Mar 2026Series D$787M
#2
Series A · Wilmington, Delaware · founded 2024$30.5Mraised▾
Developer of GenAI computational tools for drug discovery and manufacturing. The company offers a bio-LLM library with foundation models across biological languages. These models are enhanced with curated data and fine-tuned on task-specific datasets. The platform is deployed through an application layer focused on prediction, explainability, and generation. It provides AI-driven antibody discovery and optimization, protein yield maximization, and cellular response prediction. The platform ensures data privacy and security, offering complete control and fully managed infrastructure.
- Sep 2025Series A$25M
- Nov 2024Seed$5.5M
#3
Series A · Wilmington, Delaware · founded 2013 · 30 employees$6.5Mraised▾
Provider of solutions for managing manufacturing operations in manufacturing industries
- Aug 2025Series A$6.1M
- Oct 2019Series A$6M
- Dec 2017Seed—
- Jul 2014Seed$550K
#4
Seed · Dover, Delaware · founded 2024$2.7Mraised▾
Provider of an AI agent workforce tailored for life sciences companies. The platform offers pre-built AI agents for workflows such as MSL decks, internal training materials, congress posters, CME content, journal articles, MI response packages, and MLR-ready content. It integrates with tools like Veeva and PubMed to synthesize MSL notes with clinical studies, cutting research time from weeks to hours while ensuring scientifically consistent, cited outputs.
- Jun 2025Seed$2.7M
#5
Seed · Dover, Delaware · founded 2025$23Kraised▾
AI platform focused on accelerating protein engineering and drug discovery workflows. It provides accessible tools for researchers to predict, visualize, and analyze protein structures using advanced models like AlphaFold2 and ESM3.
- May 2026Seed—
- May 2026Grant (prize money)$23K
#6
Series C · Dover, Delaware · founded 2015 · 201 employees$259.3Mraised▾
Randomization and Trial Supply Management (RTSM) solutions for clinical trials. RTSM systems support the randomization of patients into different arms of a trial and the supply of study drugs to sites. It claims that its solution uses natural language specification which directly programs the system.
- Jun 2021Series C$230M
- Jan 2020Series B$14.6M
- Feb 2019Series B$7.2M
- Oct 2016Series A$5M
#7
Seed · Wilmington, Delaware · founded 2021$500Kraised▾
AI-based software for cell and gene therapy. The company is pioneering mechanistic AI to revolutionize cell and gene therapy manufacturing to make life saving therapies.
- Jun 2025Seed$500K
#8
Seed · Wilmington, Delaware · founded 2013 · 6 employees$3.9Mraised▾
Provider of cloud-based electronic laboratory log management platform. The company has developed a lab records and tasks maintenance software that allows users to report, and track records. The system has features for tracking tasks of different research instruments, get real-time data, and more.
- Jul 2024Seed$1.8M
- Mar 2024Seed$1.8M
- Oct 2021Seed$326.6K
#9
Seed · Dover, Delaware · founded 2024$3.5Mraised▾
AI-powered healthcare platform for advanced analysis of tumor lesions. The company's products include DeepPSMA fast and reproducible whole-body tumor burden quantification in CT imaging for patients with prostate cancer and SelectPSMA for the prediction of patient outcome after treatment with PSMA-targeted radiopharmaceuticals.
- Aug 2024Seed$3.5M
#10
Series A · Wilmington, Delaware · founded 2015 · 41 employees$7.7Mraised▾
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory. The platform integrates manufacturing execution, quality management, and laboratory operations into a unified digital ecosystem. It offers solutions for batch execution, quality control, environmental monitoring, and instrument management. The software aims to streamline workflows, ensure regulatory compliance, and optimize operational efficiency within pharmaceutical facilities.
- Oct 2023Series A$7M
- Jun 2020Seed$653.9K
- May 2019Seed$19.9K
#11
Funding Raised · Wilmington, Delaware · founded 2005 · 46 employees$873.2Kraised▾
Operator of a biotechnology company intended to offer an optimized alternative for separation challenges. The company uses particle technology that is specially developed to deliver hyper-fast liquid chromatographic separations, enabling clients to have improved resolution and lower detection limits.
- Jul 2023Grant (prize money)$198.2K
- May 2008Grant (prize money)$675K
#12
Series A · Dover, Delaware · founded 2010 · 28 employees$7.3Mraised▾
Inteliquet offers clinical trial solutions and services. The company offers clinical trial management solution to analyze clinical trial data and match patients to the study. It also enables users to design trials and create predictive analytics and insights.
- Aug 2014Series A$7.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Delaware researches in biotechnology
- University of Delaware22
- Delaware State University5
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.